Home › Companies › Charles River Laboratories International, Inc. › 2025-2026

Charles River Laboratories International, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Charles River Laboratories International, Inc.’s Form 8-K (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 19Reported items
  • 576Asset managers
  • 9,788Fund votes
  • 2026-05-05Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Charles River Laboratories International, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Charles River Laboratories International, Inc.

These tallies are Charles River Laboratories International, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Charles River Laboratories International, Inc. — official shareholder meeting results, meeting held 2026-05-05
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Nancy C. Andrews 42,650,2971,439,76812,630 --1,745,648 Majority: yes
Elect Director: Steven Barg 43,590,311493,25819,126 --1,745,648 Majority: yes
Elect Director: Abraham Ceesay 35,798,4268,288,77015,499 --1,745,648 Majority: yes
Elect Director: Mark Enyedy 43,555,383531,82515,487 --1,745,648 Majority: yes
Elect Director: Birgit Girshick 44,023,11267,09612,487 --1,745,648 Majority: yes
Elect Director: Paul Graves 43,921,209165,95415,532 --1,745,648 Majority: yes
Elect Director: James C. Foster 43,504,046580,00918,640 --1,745,648 Majority: yes
Elect Director: Reshema Kemps-Polanco 42,762,3591,325,99114,345 --1,745,648 Majority: yes
Elect Director: George Llado, Sr. 43,433,616624,85344,226 --1,745,648 Majority: yes
Elect Director: Martin W. Mackay 43,893,349195,75813,588 --1,745,648 Majority: yes
Elect Director: Craig B. Thompson 43,544,080543,15515,460 --1,745,648 Majority: yes
Elect Director: Virginia M. Wilson 43,590,754498,25113,690 --1,745,648 Majority: yes
(b) The shareholders approved, on an advisory, non-binding basis, the compensation of our named executive officers. 41,356,1392,716,25130,305 --1,745,648 Majority: yes
(c) The shareholders approved the 2026 Long-Term Incentive Plan. 41,523,1792,561,99417,522 --1,745,648 Majority: yes
(d) The shareholders approved the ratification of the appointment of PricewaterhouseCoopers LLP as our independent auditors for fiscal 2026. 43,646,3712,186,70015,272 --0 Majority: yes

Source: Charles River Laboratories International, Inc., Form 8-K — read the filing on EDGAR.

How asset managers voted at the Charles River Laboratories International, Inc. 2025-2026 meeting

Each item below shows how the 576 asset managers that disclosed a Charles River Laboratories International, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Charles River Laboratories International, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. ADVISORY APPROVAL OF 2025 EXECUTIVE OFFICER COMPENSATION

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2026-05-05.

Combines 8 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 41,356,139AGAINST: 2,716,251

Charles River Laboratories International, Inc.’s own tally for this item (“(b) The shareholders approved, on an advisory, non-binding basis, the compensation of our named executive officers.”): 41,356,139 for, 2,716,251 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 48,167,730 outstanding shares: 86% for, 6% against (91% of the company cast a for/against vote).

The 569 asset managers below cast 96% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR 96%
FOR: 95.7%AGAINST: 4.2%ABSTAIN: 0.0%NOT VOTED: 0.0%
Largest asset managers voting on “ADVISORY APPROVAL OF 2025 EXECUTIVE OFFICER COMPENSATION” at Charles River Laboratories International, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,709,17310 00For
Fidelity6,614,4710 00For
Invesco3,888,9930 00For
Allspring3,448,5060 00For
BlackRock2,367,3200 00For
HARRIS ASSOCIATES L P1,994,44016,567 00For
T. Rowe Price1,716,89852,217 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,572,8000 00For
GEODE CAPITAL MANAGEMENT, LLC1,300,7580 00For
Wellington1,182,2350 00For
State Street1,100,84610,316 00For
Victory Capital1,078,0496,294 00For
Columbia Threadneedle1,003,1710 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/992,7040 00For
Charles Schwab927,1350 00For
Neuberger Berman848,7010 00For
Dimensional817,0910 00For
EARNEST PARTNERS LLC193,624617,413 00Against
Amundi0725,772 00Against
COOKE & BIELER LP715,1550 00For
MFS695,1780 00For
ARIEL INVESTMENT TRUST653,4130 00For
MACKENZIE FINANCIAL CORP594,3260 00For
Clearbridge Investments, LLC570,9960 00For
ARIEL INVESTMENTS, LLC543,6690 00For

Showing the 25 largest of 569 asset managers. See all 569 in the interactive database.

2. LONG-TERM INCENTIVE PLAN

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2026-05-05.

Combines 5 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 41,523,179AGAINST: 2,561,994

Charles River Laboratories International, Inc.’s own tally for this item (“(c) The shareholders approved the 2026 Long-Term Incentive Plan.”): 41,523,179 for, 2,561,994 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 48,167,730 outstanding shares: 86% for, 5% against (92% of the company cast a for/against vote).

The 132 asset managers below cast 99.4% of the shares they voted on this item FOR (24,981,991 for, 149,499 against).

FOR 99.3%
FOR: 24,981,991 (99.4%)AGAINST: 149,499 (0.6%)ABSTAIN: 1,700 (0.0%)NOT VOTED: 40 (0.0%)
Largest asset managers voting on “LONG-TERM INCENTIVE PLAN” at Charles River Laboratories International, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,254,9026,548 00For
Fidelity3,649,0910 00For
Invesco1,905,5860 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,572,8000 00For
Allspring1,552,3140 00For
BlackRock1,478,302629 00For
Columbia Threadneedle1,003,1710 00For
MFS695,1780 00For
ARIEL INVESTMENT TRUST653,4130 00For
T. Rowe Price621,0580 00For
Dimensional588,9790 00For
State Street566,3911,029 00For
Charles Schwab457,6770 00For
Victory Capital435,9480 00For
Legg Mason285,5410 00For
Bridge Builder Trust154,8590 00For
CARILLON SERIES TRUST144,4200 00For
Federated Hermes0126,405 00Against
AB RELATIVE VALUE FUND, INC.123,7800 00For
TIAA121,7680 00For
Jackson National101,1880 00For
TEMPLETON GLOBAL SMALLER COMPANIES FUND99,9890 00For
Brighthouse99,2250 00For
Equitable88,6320 00For
MASTER INVESTMENT PORTFOLIO75,3490 00For

Showing the 25 largest of 132 asset managers. See all 132 in the interactive database.

3. Election of Directors: Nancy C. Andrews

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-05.

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 42,650,297AGAINST: 1,439,768

Charles River Laboratories International, Inc.’s own tally for this item (“Elect Director: Nancy C. Andrews”): 42,650,297 for, 1,439,768 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 48,167,730 outstanding shares: 89% for, 3% against (92% of the company cast a for/against vote).

The 127 asset managers below cast 99% of the shares they voted on this item FOR (24,847,422 for, 253,320 against).

FOR 99%
FOR: 24,847,422 (99.0%)AGAINST: 253,320 (1.0%)ABSTAIN: 9,880 (0.0%)NOT VOTED: 40 (0.0%)
Largest asset managers voting on “Election of Directors: Nancy C. Andrews” at Charles River Laboratories International, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,257,9073,543 00For
Fidelity3,590,89158,200 00For
Invesco1,905,5860 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,572,8000 00For
Allspring1,552,3140 00For
BlackRock1,478,536395 00For
Columbia Threadneedle1,003,1710 00For
MFS695,1780 00For
ARIEL INVESTMENT TRUST653,4130 00For
T. Rowe Price621,0580 00For
Dimensional588,9790 00For
State Street567,4200 00For
Charles Schwab457,569108 00For
Victory Capital435,9480 00For
Legg Mason285,5410 00For
Bridge Builder Trust86,80268,057 00For
CARILLON SERIES TRUST144,4200 00For
Federated Hermes126,4050 00For
AB RELATIVE VALUE FUND, INC.123,7800 00For
TIAA121,7680 00For
Jackson National101,1880 00For
TEMPLETON GLOBAL SMALLER COMPANIES FUND99,9890 00For
Brighthouse89,3450 9,8800For
Equitable88,6320 00For
MASTER INVESTMENT PORTFOLIO75,3490 00For

Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.

4. Election of Directors: Abraham Ceesay

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-05.

Combines 4 wordings of this item as funds reported it.

81% Majority: yes · of votes cast

FOR 81%AGAINST 19%
FOR: 35,798,426AGAINST: 8,288,770

Charles River Laboratories International, Inc.’s own tally for this item (“Elect Director: Abraham Ceesay”): 35,798,426 for, 8,288,770 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 48,167,730 outstanding shares: 74% for, 17% against (92% of the company cast a for/against vote).

The 127 asset managers below cast 87% of the shares they voted on this item FOR (21,829,348 for, 3,271,393 against).

FOR 87%13%
FOR: 21,829,348 (86.9%)AGAINST: 3,271,393 (13.0%)ABSTAIN: 9,880 (0.0%)NOT VOTED: 40 (0.0%)
Largest asset managers voting on “Election of Directors: Abraham Ceesay” at Charles River Laboratories International, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard6,858,726402,724 00For
Fidelity3,590,89158,200 00For
Invesco1,905,5860 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,572,8000 00For
Allspring1,552,3140 00For
BlackRock1,478,536395 00For
Columbia Threadneedle1,003,1710 00For
MFS0695,178 00Against
ARIEL INVESTMENT TRUST653,4130 00For
T. Rowe Price621,0580 00For
Dimensional0588,979 00Against
State Street567,4128 00For
Charles Schwab299457,377 00Against
Victory Capital435,9480 00For
Legg Mason284,948593 00For
Bridge Builder Trust86,80268,057 00For
CARILLON SERIES TRUST144,4200 00For
Federated Hermes0126,405 00Against
AB RELATIVE VALUE FUND, INC.0123,780 00Against
TIAA121,7680 00For
Jackson National41,01760,171 00Against
TEMPLETON GLOBAL SMALLER COMPANIES FUND099,989 00Against
Brighthouse74,15915,186 9,8800For
Equitable37,90250,730 00Against
MASTER INVESTMENT PORTFOLIO75,3490 00For

Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.

5. Election of Directors: James C. Foster

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-05.

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 43,504,046AGAINST: 580,009

Charles River Laboratories International, Inc.’s own tally for this item (“Elect Director: James C. Foster”): 43,504,046 for, 580,009 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 48,167,730 outstanding shares: 90% for, 1% against (92% of the company cast a for/against vote).

The 127 asset managers below cast 99.9% of the shares they voted on this item FOR (25,100,740 for, 2 against).

FOR 99.9%
FOR: 25,100,740 (100.0%)AGAINST: 2 (0.0%)ABSTAIN: 9,880 (0.0%)NOT VOTED: 40 (0.0%)
Largest asset managers voting on “Election of Directors: James C. Foster” at Charles River Laboratories International, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,261,4482 00For
Fidelity3,649,0910 00For
Invesco1,905,5860 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,572,8000 00For
Allspring1,552,3140 00For
BlackRock1,478,9310 00For
Columbia Threadneedle1,003,1710 00For
MFS695,1780 00For
ARIEL INVESTMENT TRUST653,4130 00For
T. Rowe Price621,0580 00For
Dimensional588,9790 00For
State Street567,4200 00For
Charles Schwab457,6770 00For
Victory Capital435,9480 00For
Legg Mason285,5410 00For
Bridge Builder Trust154,8590 00For
CARILLON SERIES TRUST144,4200 00For
Federated Hermes126,4050 00For
AB RELATIVE VALUE FUND, INC.123,7800 00For
TIAA121,7680 00For
Jackson National101,1880 00For
TEMPLETON GLOBAL SMALLER COMPANIES FUND99,9890 00For
Brighthouse89,3450 9,8800For
Equitable88,6320 00For
MASTER INVESTMENT PORTFOLIO75,3490 00For

Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.

6. Election of Directors: Birgit Girshick

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-05.

Combines 4 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%
FOR: 44,023,112AGAINST: 67,096

Charles River Laboratories International, Inc.’s own tally for this item (“Elect Director: Birgit Girshick”): 44,023,112 for, 67,096 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 48,167,730 outstanding shares: 91% for, 0.2% against (92% of the company cast a for/against vote).

The 127 asset managers below cast 100% of the shares they voted on this item FOR (25,100,742 for, 0 against).

FOR 99.9%
FOR: 25,100,742 (100.0%)ABSTAIN: 9,880 (0.0%)NOT VOTED: 40 (0.0%)
Largest asset managers voting on “Election of Directors: Birgit Girshick” at Charles River Laboratories International, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,261,4500 00For
Fidelity3,649,0910 00For
Invesco1,905,5860 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,572,8000 00For
Allspring1,552,3140 00For
BlackRock1,478,9310 00For
Columbia Threadneedle1,003,1710 00For
MFS695,1780 00For
ARIEL INVESTMENT TRUST653,4130 00For
T. Rowe Price621,0580 00For
Dimensional588,9790 00For
State Street567,4200 00For
Charles Schwab457,6770 00For
Victory Capital435,9480 00For
Legg Mason285,5410 00For
Bridge Builder Trust154,8590 00For
CARILLON SERIES TRUST144,4200 00For
Federated Hermes126,4050 00For
AB RELATIVE VALUE FUND, INC.123,7800 00For
TIAA121,7680 00For
Jackson National101,1880 00For
TEMPLETON GLOBAL SMALLER COMPANIES FUND99,9890 00For
Brighthouse89,3450 9,8800For
Equitable88,6320 00For
MASTER INVESTMENT PORTFOLIO75,3490 00For

Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.

7. Election of Directors: Reshema Kemps-Polanco

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-05.

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 42,762,359AGAINST: 1,325,991

Charles River Laboratories International, Inc.’s own tally for this item (“Elect Director: Reshema Kemps-Polanco”): 42,762,359 for, 1,325,991 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 48,167,730 outstanding shares: 89% for, 3% against (92% of the company cast a for/against vote).

The 127 asset managers below cast 99.9% of the shares they voted on this item FOR (25,100,689 for, 53 against).

FOR 99.9%
FOR: 25,100,689 (100.0%)AGAINST: 53 (0.0%)ABSTAIN: 9,880 (0.0%)NOT VOTED: 40 (0.0%)
Largest asset managers voting on “Election of Directors: Reshema Kemps-Polanco” at Charles River Laboratories International, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,261,4455 00For
Fidelity3,649,0910 00For
Invesco1,905,5860 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,572,8000 00For
Allspring1,552,3140 00For
BlackRock1,478,9310 00For
Columbia Threadneedle1,003,1710 00For
MFS695,1780 00For
ARIEL INVESTMENT TRUST653,4130 00For
T. Rowe Price621,0580 00For
Dimensional588,9790 00For
State Street567,4200 00For
Charles Schwab457,6770 00For
Victory Capital435,9480 00For
Legg Mason285,5410 00For
Bridge Builder Trust154,8590 00For
CARILLON SERIES TRUST144,4200 00For
Federated Hermes126,4050 00For
AB RELATIVE VALUE FUND, INC.123,7800 00For
TIAA121,7680 00For
Jackson National101,1880 00For
TEMPLETON GLOBAL SMALLER COMPANIES FUND99,9890 00For
Brighthouse89,3450 9,8800For
Equitable88,6320 00For
MASTER INVESTMENT PORTFOLIO75,3490 00For

Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.

8. Election of Directors: Martin Mackay

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-05.

Combines 5 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 43,893,349AGAINST: 195,758

Charles River Laboratories International, Inc.’s own tally for this item (“Elect Director: Martin W. Mackay”): 43,893,349 for, 195,758 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 48,167,730 outstanding shares: 91% for, 0.5% against (92% of the company cast a for/against vote).

The 127 asset managers below cast 99.9% of the shares they voted on this item FOR (25,087,552 for, 13,189 against).

FOR 99.9%
FOR: 25,087,552 (99.9%)AGAINST: 13,189 (0.1%)ABSTAIN: 9,880 (0.0%)NOT VOTED: 40 (0.0%)
Largest asset managers voting on “Election of Directors: Martin Mackay” at Charles River Laboratories International, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,261,4490 00For
Fidelity3,649,0910 00For
Invesco1,905,5860 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,572,8000 00For
Allspring1,552,3140 00For
BlackRock1,478,9310 00For
Columbia Threadneedle1,003,1710 00For
MFS695,1780 00For
ARIEL INVESTMENT TRUST653,4130 00For
T. Rowe Price621,0580 00For
Dimensional588,9790 00For
State Street567,4200 00For
Charles Schwab457,6770 00For
Victory Capital435,9480 00For
Legg Mason285,5410 00For
Bridge Builder Trust154,8590 00For
CARILLON SERIES TRUST144,4200 00For
Federated Hermes126,4050 00For
AB RELATIVE VALUE FUND, INC.123,7800 00For
TIAA121,7680 00For
Jackson National101,1880 00For
TEMPLETON GLOBAL SMALLER COMPANIES FUND99,9890 00For
Brighthouse89,3450 9,8800For
Equitable88,6320 00For
MASTER INVESTMENT PORTFOLIO75,3490 00For

Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.

9. Election of Directors: Craig B. Thompson

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-05.

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 43,544,080AGAINST: 543,155

Charles River Laboratories International, Inc.’s own tally for this item (“Elect Director: Craig B. Thompson”): 43,544,080 for, 543,155 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 48,167,730 outstanding shares: 90% for, 1% against (92% of the company cast a for/against vote).

The 127 asset managers below cast 99.9% of the shares they voted on this item FOR (25,092,146 for, 7,573 against).

FOR 99.9%
FOR: 25,092,146 (99.9%)AGAINST: 7,573 (0.0%)ABSTAIN: 10,901 (0.0%)NOT VOTED: 40 (0.0%)
Largest asset managers voting on “Election of Directors: Craig B. Thompson” at Charles River Laboratories International, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,254,9096,540 00For
Fidelity3,649,0910 00For
Invesco1,905,5860 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,572,8000 00For
Allspring1,552,3140 00For
BlackRock1,478,302629 00For
Columbia Threadneedle1,003,1710 00For
MFS695,1780 00For
ARIEL INVESTMENT TRUST653,4130 00For
T. Rowe Price621,0580 00For
Dimensional588,9790 00For
State Street566,3990 1,0210For
Charles Schwab457,6770 00For
Victory Capital435,9480 00For
Legg Mason285,5410 00For
Bridge Builder Trust154,8590 00For
CARILLON SERIES TRUST144,4200 00For
Federated Hermes126,4050 00For
AB RELATIVE VALUE FUND, INC.123,7800 00For
TIAA121,7680 00For
Jackson National101,1880 00For
TEMPLETON GLOBAL SMALLER COMPANIES FUND99,9890 00For
Brighthouse89,3450 9,8800For
Equitable88,6320 00For
MASTER INVESTMENT PORTFOLIO75,3490 00For

Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.

10. Election of Directors: Virginia Wilson

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-05.

Combines 5 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 43,590,754AGAINST: 498,251

Charles River Laboratories International, Inc.’s own tally for this item (“Elect Director: Virginia M. Wilson”): 43,590,754 for, 498,251 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 48,167,730 outstanding shares: 90% for, 1% against (92% of the company cast a for/against vote).

The 127 asset managers below cast 99.9% of the shares they voted on this item FOR (25,100,741 for, 1 against).

FOR 99.9%
FOR: 25,100,741 (100.0%)AGAINST: 1 (0.0%)ABSTAIN: 9,880 (0.0%)NOT VOTED: 40 (0.0%)
Largest asset managers voting on “Election of Directors: Virginia Wilson” at Charles River Laboratories International, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,261,4491 00For
Fidelity3,649,0910 00For
Invesco1,905,5860 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,572,8000 00For
Allspring1,552,3140 00For
BlackRock1,478,9310 00For
Columbia Threadneedle1,003,1710 00For
MFS695,1780 00For
ARIEL INVESTMENT TRUST653,4130 00For
T. Rowe Price621,0580 00For
Dimensional588,9790 00For
State Street567,4200 00For
Charles Schwab457,6770 00For
Victory Capital435,9480 00For
Legg Mason285,5410 00For
Bridge Builder Trust154,8590 00For
CARILLON SERIES TRUST144,4200 00For
Federated Hermes126,4050 00For
AB RELATIVE VALUE FUND, INC.123,7800 00For
TIAA121,7680 00For
Jackson National101,1880 00For
TEMPLETON GLOBAL SMALLER COMPANIES FUND99,9890 00For
Brighthouse89,3450 9,8800For
Equitable88,6320 00For
MASTER INVESTMENT PORTFOLIO75,3490 00For

Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.

11. Election of Directors: Steven Barg

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-05.

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 43,590,311AGAINST: 493,258

Charles River Laboratories International, Inc.’s own tally for this item (“Elect Director: Steven Barg”): 43,590,311 for, 493,258 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 48,167,730 outstanding shares: 90% for, 1% against (92% of the company cast a for/against vote).

The 126 asset managers below cast 99.9% of the shares they voted on this item FOR (25,099,900 for, 1 against).

FOR 99.9%
FOR: 25,099,900 (100.0%)AGAINST: 1 (0.0%)ABSTAIN: 9,880 (0.0%)NOT VOTED: 40 (0.0%)
Largest asset managers voting on “Election of Directors: Steven Barg” at Charles River Laboratories International, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,261,4491 00For
Fidelity3,649,0910 00For
Invesco1,905,5860 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,572,8000 00For
Allspring1,552,3140 00For
BlackRock1,478,9310 00For
Columbia Threadneedle1,003,1710 00For
MFS695,1780 00For
ARIEL INVESTMENT TRUST653,4130 00For
T. Rowe Price621,0580 00For
Dimensional588,9790 00For
State Street567,4200 00For
Charles Schwab457,6770 00For
Victory Capital435,9480 00For
Legg Mason285,5410 00For
Bridge Builder Trust154,8590 00For
CARILLON SERIES TRUST144,4200 00For
Federated Hermes126,4050 00For
AB RELATIVE VALUE FUND, INC.123,7800 00For
TIAA121,7680 00For
Jackson National101,1880 00For
TEMPLETON GLOBAL SMALLER COMPANIES FUND99,9890 00For
Brighthouse89,3450 9,8800For
Equitable88,6320 00For
MASTER INVESTMENT PORTFOLIO75,3490 00For

Showing the 25 largest of 126 asset managers. See all 126 in the interactive database.

12. Election of Directors: Mark Enyedy

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-05.

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 43,555,383AGAINST: 531,825

Charles River Laboratories International, Inc.’s own tally for this item (“Elect Director: Mark Enyedy”): 43,555,383 for, 531,825 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 48,167,730 outstanding shares: 90% for, 1% against (92% of the company cast a for/against vote).

The 126 asset managers below cast 99.8% of the shares they voted on this item FOR (25,066,237 for, 33,664 against).

FOR 99.8%
FOR: 25,066,237 (99.8%)AGAINST: 33,664 (0.1%)ABSTAIN: 9,880 (0.0%)NOT VOTED: 40 (0.0%)
Largest asset managers voting on “Election of Directors: Mark Enyedy” at Charles River Laboratories International, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,261,4491 00For
Fidelity3,649,0910 00For
Invesco1,905,5860 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,572,8000 00For
Allspring1,552,3140 00For
BlackRock1,478,9310 00For
Columbia Threadneedle1,003,1710 00For
MFS695,1780 00For
ARIEL INVESTMENT TRUST653,4130 00For
T. Rowe Price621,0580 00For
Dimensional588,9790 00For
State Street567,4200 00For
Charles Schwab457,6770 00For
Victory Capital435,9480 00For
Legg Mason285,5410 00For
Bridge Builder Trust154,8590 00For
CARILLON SERIES TRUST144,4200 00For
Federated Hermes126,4050 00For
AB RELATIVE VALUE FUND, INC.123,7800 00For
TIAA121,7680 00For
Jackson National101,1880 00For
TEMPLETON GLOBAL SMALLER COMPANIES FUND99,9890 00For
Brighthouse89,3450 9,8800For
Equitable88,6320 00For
MASTER INVESTMENT PORTFOLIO75,3490 00For

Showing the 25 largest of 126 asset managers. See all 126 in the interactive database.

13. Election of Directors: Paul Graves

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-05.

Combines 3 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 43,921,209AGAINST: 165,954

Charles River Laboratories International, Inc.’s own tally for this item (“Elect Director: Paul Graves”): 43,921,209 for, 165,954 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 48,167,730 outstanding shares: 91% for, 0.4% against (92% of the company cast a for/against vote).

The 126 asset managers below cast 100% of the shares they voted on this item FOR (25,099,901 for, 0 against).

FOR 99.9%
FOR: 25,099,901 (100.0%)ABSTAIN: 9,880 (0.0%)NOT VOTED: 40 (0.0%)
Largest asset managers voting on “Election of Directors: Paul Graves” at Charles River Laboratories International, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,261,4500 00For
Fidelity3,649,0910 00For
Invesco1,905,5860 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,572,8000 00For
Allspring1,552,3140 00For
BlackRock1,478,9310 00For
Columbia Threadneedle1,003,1710 00For
MFS695,1780 00For
ARIEL INVESTMENT TRUST653,4130 00For
T. Rowe Price621,0580 00For
Dimensional588,9790 00For
State Street567,4200 00For
Charles Schwab457,6770 00For
Victory Capital435,9480 00For
Legg Mason285,5410 00For
Bridge Builder Trust154,8590 00For
CARILLON SERIES TRUST144,4200 00For
Federated Hermes126,4050 00For
AB RELATIVE VALUE FUND, INC.123,7800 00For
TIAA121,7680 00For
Jackson National101,1880 00For
TEMPLETON GLOBAL SMALLER COMPANIES FUND99,9890 00For
Brighthouse89,3450 9,8800For
Equitable88,6320 00For
MASTER INVESTMENT PORTFOLIO75,3490 00For

Showing the 25 largest of 126 asset managers. See all 126 in the interactive database.

14. Election of Directors: George Llado

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-05.

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 43,433,616AGAINST: 624,853

Charles River Laboratories International, Inc.’s own tally for this item (“Elect Director: George Llado, Sr.”): 43,433,616 for, 624,853 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 48,167,730 outstanding shares: 90% for, 1% against (91% of the company cast a for/against vote).

The 126 asset managers below cast 99.8% of the shares they voted on this item FOR (25,066,235 for, 33,666 against).

FOR 99.8%
FOR: 25,066,235 (99.8%)AGAINST: 33,666 (0.1%)ABSTAIN: 9,880 (0.0%)NOT VOTED: 40 (0.0%)
Largest asset managers voting on “Election of Directors: George Llado” at Charles River Laboratories International, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,261,4473 00For
Fidelity3,649,0910 00For
Invesco1,905,5860 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,572,8000 00For
Allspring1,552,3140 00For
BlackRock1,478,9310 00For
Columbia Threadneedle1,003,1710 00For
MFS695,1780 00For
ARIEL INVESTMENT TRUST653,4130 00For
T. Rowe Price621,0580 00For
Dimensional588,9790 00For
State Street567,4200 00For
Charles Schwab457,6770 00For
Victory Capital435,9480 00For
Legg Mason285,5410 00For
Bridge Builder Trust154,8590 00For
CARILLON SERIES TRUST144,4200 00For
Federated Hermes126,4050 00For
AB RELATIVE VALUE FUND, INC.123,7800 00For
TIAA121,7680 00For
Jackson National101,1880 00For
TEMPLETON GLOBAL SMALLER COMPANIES FUND99,9890 00For
Brighthouse89,3450 9,8800For
Equitable88,6320 00For
MASTER INVESTMENT PORTFOLIO75,3490 00For

Showing the 25 largest of 126 asset managers. See all 126 in the interactive database.

15. Ratification of PricewaterhouseCoopers LLC as independent registered public accounting firm for 2026

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2026-05-05.

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 43,646,371AGAINST: 2,186,700

Charles River Laboratories International, Inc.’s own tally for this item (“(d) The shareholders approved the ratification of the appointment of PricewaterhouseCoopers LLP as our independent auditors for fiscal 2026.”): 43,646,371 for, 2,186,700 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 48,167,730 outstanding shares: 91% for, 5% against (95% of the company cast a for/against vote).

The 126 asset managers below cast 99.9% of the shares they voted on this item FOR (25,073,833 for, 17,754 against).

FOR 99.8%
FOR: 25,073,833 (99.9%)AGAINST: 17,754 (0.1%)ABSTAIN: 9,880 (0.0%)NOT VOTED: 40 (0.0%)
Largest asset managers voting on “Ratification of PricewaterhouseCoopers LLC as independent registered public accounting firm for 2026” at Charles River Laboratories International, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,257,9053,545 00For
Fidelity3,649,0910 00For
Invesco1,905,5860 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,572,8000 00For
Allspring1,552,3140 00For
BlackRock1,478,724207 00For
Columbia Threadneedle1,003,1710 00For
MFS695,1780 00For
ARIEL INVESTMENT TRUST653,4130 00For
T. Rowe Price621,0580 00For
Dimensional588,9790 00For
State Street567,4128 00For
Charles Schwab457,6770 00For
Victory Capital435,9480 00For
Legg Mason285,5410 00For
Bridge Builder Trust154,8590 00For
CARILLON SERIES TRUST144,4200 00For
Federated Hermes126,4050 00For
AB RELATIVE VALUE FUND, INC.123,7800 00For
TIAA121,7680 00For
Jackson National101,1880 00For
TEMPLETON GLOBAL SMALLER COMPANIES FUND99,9890 00For
Brighthouse89,3450 9,8800For
Equitable88,6320 00For
MASTER INVESTMENT PORTFOLIO75,3490 00For

Showing the 25 largest of 126 asset managers. See all 126 in the interactive database.

16. Approve Omnibus Stock Plan

COMPENSATION

Meeting held 2026-05-05.

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (9,212 for, 0 against).

FOR: 9,212 (100.0%)
Largest asset managers voting on “Approve Omnibus Stock Plan” at Charles River Laboratories International, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Empower8,2980 00For
CLEARWATER INVESTMENT TRUST8560 00For
Sepio Capital, LP580 00For

17. Ratify PricewaterhouseCoopers LLP as Auditors

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2026-05-05.

Combines 2 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 43,646,371AGAINST: 2,186,700

Charles River Laboratories International, Inc.’s own tally for this item (“(d) The shareholders approved the ratification of the appointment of PricewaterhouseCoopers LLP as our independent auditors for fiscal 2026.”): 43,646,371 for, 2,186,700 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 48,167,730 outstanding shares: 91% for, 5% against (95% of the company cast a for/against vote).

The 3 asset managers below cast 100% of the shares they voted on this item FOR (12,154 for, 0 against).

FOR 100%
FOR: 12,154 (100.0%)
Largest asset managers voting on “Ratify PricewaterhouseCoopers LLP as Auditors” at Charles River Laboratories International, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Empower8,2980 00For
WILLIAMSBURG INVESTMENT TRUST3,0000 00For
CLEARWATER INVESTMENT TRUST8560 00For

18. Approve Stock Compensation Plan

COMPENSATION

Meeting held 2026-05-05.

0% fund support · no official result

AGAINST 50.2%ABSTAIN 49.8%

The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 3,026 against).

AGAINST: 3,026 (50.2%)ABSTAIN: 3,000 (49.8%)
Largest asset managers voting on “Approve Stock Compensation Plan” at Charles River Laboratories International, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
LEAVELL INVESTMENT MANAGEMENT, INC.03,026 00Against
WILLIAMSBURG INVESTMENT TRUST00 3,0000Abstain

19. Advisory Approval of 2024 Executive Officer Compensation

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-05-20 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (120,629 for, 0 against).

FOR: 120,629 (100.0%)
Largest asset managers voting on “Advisory Approval of 2024 Executive Officer Compensation” at Charles River Laboratories International, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
NORRIS PERNE & FRENCH LLP/MI120,6100 00For
OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC190 00For

Largest Charles River Laboratories International, Inc. shareholders voting in 2025-2026

Ranked by the number of Charles River Laboratories International, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 48,167,730 shares outstanding at the time of that meeting.

Top Charles River Laboratories International, Inc. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 16.00%
2Fidelity 13.73%
3Invesco 8.07%
4Allspring 7.16%
5BlackRock 4.91%
6HARRIS ASSOCIATES L P 4.18%
7T. Rowe Price 3.67%
8HARRIS ASSOCIATES INVESTMENT TRUST 3.27%
9GEODE CAPITAL MANAGEMENT, LLC 2.70%
10Wellington 2.45%

Reported Charles River Laboratories International, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Charles River Laboratories International, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
Vanguard Group 12.22% 13F
BlackRock 8.01% 13F
FMR (Fidelity) 7.18% 13F
Invesco 4.98% 13F
State Street 3.89% 13F
Dimensional Fund Advisors 3.43% 13F
Wellington Management 3.38% 13F
Citadel Advisors 2.60% 13F
T. Rowe Price 2.34% 13F
James C. Foster 0.75% DEF14A

Percentages above are of 48,167,730 shares outstanding, as reported by Charles River Laboratories International, Inc. on its Form 10-Q dated 2026-04-24 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Charles River Laboratories International, Inc.’s 10-Q dated 2026-04-24. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At Charles River Laboratories International, Inc.'s shareholder meeting held 2026-05-05, in the 2025-2026 proxy season, 576 asset managers reported how they voted in their SEC Form N-PX filings, covering 9,788 separate fund positions. Their filings are grouped here into 19 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — ADVISORY APPROVAL OF 2025 EXECUTIVE OFFICER COMPENSATION — FOR was 94% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Charles River Laboratories International, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission (filing date not recorded for this item).

Charles River Laboratories International, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).